Coghill, DR, Banaschewski, T, Bliss, C, Robertson, B, Zuddas, A.
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate.
CNS Drugs
32(1)
:
85 -95
2018
view publication
Sayal, K, Prasad, V, Daley, D, Ford, T, Coghill, D.
Barriers to medication entitlements after diagnosis of ADHD – Authors' reply.
The Lancet Psychiatry
5(1)
:
19 -20
2018
view publication
Coghill, DR, Banaschewski, T, Soutullo, C, Cottingham, MG, Zuddas, A.
Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder.
European Child & Adolescent Psychiatry
26(11)
:
1283 -1307
2017
view publication
Coghill, DR.
Organisation of services for managing ADHD.
Epidemiology and Psychiatric Sciences
26(5)
:
453 -458
2017
view publication
Banaschewski, T, Zuddas, A, Bliss, C, Robertson, B, Coghill, D.
P.1.j.030 Cognitive function in children and adolescents with ADHD receiving lisdexamfetamine dimesylate in a 2-year safety study.
European Neuropsychopharmacology
27:
s737
2017
view publication
